PPIs vs H2RAs for erosive reflux esophagitis.
作者信息
King V J
机构信息
University of North Carolina, Chapel Hill, USA.
出版信息
J Fam Pract. 1998 Mar;46(3):199-200.
PMID:9519012
Abstract
摘要
相似文献
1
PPIs vs H2RAs for erosive reflux esophagitis.质子泵抑制剂与组胺H2受体拮抗剂治疗糜烂性反流性食管炎的比较
J Fam Pract. 1998 Mar;46(3):199-200.
2
3
4
"Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.质子泵抑制剂优先策略与逐步升级策略用于反流性食管炎急性治疗的比较：日本的成本效益分析
J Gastroenterol. 2005 Nov;40(11):1029-35. doi: 10.1007/s00535-005-1704-y.
5
Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.雷贝拉唑与非专利法莫替丁治疗糜烂性食管炎患者症状缓解的成本效益。
Am J Manag Care. 2000 Aug;6(8):905-16.
6
[Cost-effectiveness analysis for the treatment of non-erosive reflux disease].[非糜烂性反流病治疗的成本效益分析]
Nihon Rinsho. 2007 May;65(5):951-5.
7
Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.奥美拉唑与高剂量雷尼替丁治疗轻度胃食管反流病的短期和长期疗效。荷兰反流研究小组。
Am J Gastroenterol. 1999 Apr;94(4):931-6. doi: 10.1111/j.1572-0241.1999.989_l.x.
8
9
Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
Am J Manag Care. 2000 Aug;6(8):934-5.
10
A practice-based approach for converting from proton pump inhibitors to less costly therapy.一种基于实践的从质子泵抑制剂转换为成本较低治疗方法的途径。
Eff Clin Pract. 2001 Nov-Dec;4(6):263-70.
Zotero 插件